170 related articles for article (PubMed ID: 17768831)
1. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
Fakhouri F
Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
[TBL] [Abstract][Full Text] [Related]
3. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
[TBL] [Abstract][Full Text] [Related]
4. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
Ahsan N
J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
8. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
Decocq G; de Cagny B; Andréjak M; Desablens B
Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
[TBL] [Abstract][Full Text] [Related]
9. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.
Cayco AV; Perazella MA; Hayslett JP
J Am Soc Nephrol; 1997 Nov; 8(11):1788-94. PubMed ID: 9355083
[TBL] [Abstract][Full Text] [Related]
10. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
[TBL] [Abstract][Full Text] [Related]
11. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
[TBL] [Abstract][Full Text] [Related]
12. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC
Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Dantal J
Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin and the kidney--a two-edged sword.
Orbach H; Tishler M; Shoenfeld Y
Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
[TBL] [Abstract][Full Text] [Related]
15. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman.
Kwan TH; Tong MK; Siu YP; Leung KT; Lee HK; Yung CY; Au TC
Hong Kong Med J; 2005 Feb; 11(1):45-9. PubMed ID: 15687516
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
Welles CC; Tambra S; Lafayette RA
Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of intravenous immunoglobulin in the setting of liver transplantation or HBV-related cirrhosis: an undervalued topic.
Angeli P; Scaglione F
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):259-75. PubMed ID: 18614975
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure following intravenous administration of hepatitis B im-munoglobulin in liver transplantation.
Donataccio M; Dalle Ore G; Donataccio D
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):501-4. PubMed ID: 19942832
[TBL] [Abstract][Full Text] [Related]
20. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
